T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.76B |
| 2 |
Eli Lilly
LLY
|
+$1.4B |
| 3 |
Bank of America
BAC
|
+$1.3B |
| 4 |
Tesla
TSLA
|
+$1.19B |
| 5 |
Wells Fargo
WFC
|
+$784M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$6.47B |
| 2 |
Amazon
AMZN
|
+$3.71B |
| 3 |
Yum! Brands
YUM
|
+$2.84B |
| 4 |
Salesforce
CRM
|
+$2.77B |
| 5 |
Fortive
FTV
|
+$2.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.07% |
| 2 | Healthcare | 18.73% |
| 3 | Consumer Discretionary | 14.62% |
| 4 | Financials | 10.39% |
| 5 | Communication Services | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SYNH
1426
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $2.13M | ﹤0.01% |
45,274
+4,346
| +11% | +$281K |
|
1427
MDU Resources
MDU
$4.35B
| $2.13M | ﹤0.01% |
204,810
+30,504
| +18% | +$337K |
|
|
CTEV
1428
Claritev Corp
CTEV
$680M
| $2.13M | ﹤0.01% |
18,595
-928,943
| -98% | -$154M |
|
1429
Autoliv
ALV
$8.96B
| $2.12M | ﹤0.01% |
31,845
+363
| +1% | +$28.1K |
|
1430
Valley National Bancorp
VLY
$8.29B
| $2.11M | ﹤0.01% |
195,046
-28,470
| -13% | -$328K |
|
1431
Terex
TEX
$7.75B
| $2.1M | ﹤0.01% |
70,559
+5,046
| +8% | +$165K |
|
1432
Kratos Defense & Security Solutions
KTOS
$12.2B
| $2.09M | ﹤0.01% |
205,897
-2,499,767
| -92% | -$33.5M |
|
1433
Hawaiian Electric Industries
HE
$2.06B
| $2.08M | ﹤0.01% |
60,141
+9,599
| +19% | +$386K |
|
1434
Bank OZK
OZK
$5.73B
| $2.08M | ﹤0.01% |
52,489
+6,744
| +15% | +$271K |
|
|
BFS
1435
Saul Centers
BFS
$863M
| $2.07M | ﹤0.01% |
55,275
-2,107,263
| -97% | -$97.1M |
|
1436
Prelude Therapeutics
PRLD
$433M
| $2.07M | ﹤0.01% |
313,165
+5,812
| +2% | +$39.2K |
|
1437
Mitsubishi UFJ Financial
MUFG
$259B
| $2.07M | ﹤0.01% |
+457,377
| New | +$2.38M |
|
|
HTLF
1438
DELISTED
Heartland Financial USA, Inc.
HTLF
| $2.07M | ﹤0.01% |
47,695
+5,209
| +12% | +$231K |
|
1439
Cabot Corp
CBT
$4.5B
| $2.07M | ﹤0.01% |
32,332
-3,949
| -11% | -$278K |
|
1440
Harley-Davidson
HOG
$2.91B
| $2.06M | ﹤0.01% |
59,000
+1,779
| +3% | +$66.8K |
|
1441
Nuvation Bio
NUVB
$2.13B
| $2.04M | ﹤0.01% |
911,533
+826,426
| +971% | +$2.36M |
|
|
TEAD
1442
Teads Holding Co
TEAD
$67.2M
| $2.03M | ﹤0.01% |
556,102
+103,367
| +23% | +$502K |
|
1443
CVB Financial
CVBF
$4.1B
| $2.03M | ﹤0.01% |
80,123
+10,480
| +15% | +$273K |
|
1444
Universal Display
OLED
$4.11B
| $2.02M | ﹤0.01% |
21,445
+150
| +0.7% | +$16.6K |
|
1445
Rogers Corp
ROG
$2.53B
| $2.02M | ﹤0.01% |
8,360
+1,219
| +17% | +$316K |
|
1446
Fluor
FLR
$7.12B
| $2.02M | ﹤0.01% |
81,123
-9,086
| -10% | -$232K |
|
|
JBGS
1447
JBG SMITH
JBGS
$692M
| $2M | ﹤0.01% |
107,815
-4,336,450
| -98% | -$99.4M |
|
1448
Capitol Federal Financial
CFFN
$1.09B
| $1.99M | ﹤0.01% |
240,009
-5,830,929
| -96% | -$54.2M |
|
1449
Sonoco
SON
$5.74B
| $1.99M | ﹤0.01% |
34,997
-2,906
| -8% | -$179K |
|
1450
Oshkosh
OSK
$9.48B
| $1.99M | ﹤0.01% |
28,237
-10,492
| -27% | -$853K |
|
Similar funds
T. Rowe Price Associates's Q3 2022 Portfolio in Review
As of Q3 2022, T. Rowe Price Associates held 3,114 positions worth $610B, down 23% from $791B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
T. Rowe Price Associates withdrew a net $168B in Q3 2022, closing 171 positions and reducing 1,248 holdings. Its most notable exit was Alcon, an estimated $1.51B position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, T. Rowe Price Associates opened a new position in Corebridge Financial worth $194M.
- T. Rowe Price Associates's largest Q3 2022 buy was Corebridge Financial: 9,831,688 shares worth $194M.
- T. Rowe Price Associates added most to ExxonMobil in Q3 2022, an estimated $1.76B increase.
- T. Rowe Price Associates's biggest Q3 2022 reduction was Microsoft, cutting an estimated $6.47B.
- T. Rowe Price Associates fully exited Alcon in Q3 2022, selling an estimated $1.51B.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $610B portfolio in Q3 2022.
- T. Rowe Price Associates opened 154 new positions and closed 171 in Q3 2022.
- T. Rowe Price Associates's portfolio value fell 23% quarter-over-quarter to $610B.
Based on T. Rowe Price Associates's 13F filing for Q3 2022, filed 14 Nov 2022.